164 related articles for article (PubMed ID: 36894556)
1. Lantern-shaped flexible RNA origami for Smad4 mRNA delivery and growth suppression of colorectal cancer.
Hu M; Feng C; Yuan Q; Liu C; Ge B; Sun F; Zhu X
Nat Commun; 2023 Mar; 14(1):1307. PubMed ID: 36894556
[TBL] [Abstract][Full Text] [Related]
2. Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer.
Wang Z; Yang J; Di J; Cui M; Xing J; Wu F; Wu W; Yang H; Zhang C; Yao Z; Zhang N; Jiang B; Su X
Sci Rep; 2017 Jun; 7(1):4281. PubMed ID: 28655924
[TBL] [Abstract][Full Text] [Related]
3. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Smad4 enhances proliferation and invasion of colorectal carcinoma HCT116 cells and up-regulates Id2.
Shi Q; Zhong YS; Yao LQ; Li QL; Ren Z; Liu XP; Shi FM
Mol Med Rep; 2012 Jan; 5(1):89-95. PubMed ID: 21956276
[TBL] [Abstract][Full Text] [Related]
5. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
[TBL] [Abstract][Full Text] [Related]
6. SMAD4 in early onset colorectal cancer.
Perea J; García-Nebreda M; Hidalgo M; Urioste M
Colorectal Dis; 2010 Sep; 12(9):948. PubMed ID: 20456468
[No Abstract] [Full Text] [Related]
7. Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer.
Liu Y; Sheng J; Dai D; Liu T; Qi F
Pathol Res Pract; 2015 Apr; 211(4):286-92. PubMed ID: 25680269
[TBL] [Abstract][Full Text] [Related]
8. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
[TBL] [Abstract][Full Text] [Related]
9. Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.
Refaat B; Zekri J; Aslam A; Ahmad J; Baghdadi MA; Meliti A; Idris S; Sultan S; Alardati H; Saimeh HA; Alsaegh A; Alhadrami M; Hamid T; Naeem ME; Elsamany SA
Pathol Oncol Res; 2021; 27():1610032. PubMed ID: 34867090
[TBL] [Abstract][Full Text] [Related]
10. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Jia X; Shanmugam C; Paluri RK; Jhala NC; Behring MP; Katkoori VR; Sugandha SP; Bae S; Samuel T; Manne U
Oncotarget; 2017 Mar; 8(12):20198-20212. PubMed ID: 28423626
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
Singh P; Wig JD; Srinivasan R; Radotra BD
Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
[TBL] [Abstract][Full Text] [Related]
13. A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer.
Szeglin BC; Wu C; Marco MR; Park HS; Zhang Z; Zhang B; Garcia-Aguilar J; Beauchamp RD; Chen XS; Smith JJ
Cancer Rep (Hoboken); 2022 Jan; 5(1):e1423. PubMed ID: 34114372
[TBL] [Abstract][Full Text] [Related]
14. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
15. Antimetastatic role of Smad4 signaling in colorectal cancer.
Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
[TBL] [Abstract][Full Text] [Related]
16. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
[TBL] [Abstract][Full Text] [Related]
18. SMAD4 levels and response to 5-fluorouracil in colorectal cancer.
Alhopuro P; Alazzouzi H; Sammalkorpi H; Dávalos V; Salovaara R; Hemminki A; Järvinen H; Mecklin JP; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Sep; 11(17):6311-6. PubMed ID: 16144935
[TBL] [Abstract][Full Text] [Related]
19. The role of SMAD4 in early-onset colorectal cancer.
Royce SG; Alsop K; Haydon A; Mead L; Smith LD; Tesoriero AA; Giles GG; Jenkins MA; Hopper JL; Southey MC
Colorectal Dis; 2010 Mar; 12(3):213-9. PubMed ID: 19183329
[TBL] [Abstract][Full Text] [Related]
20. SMAD4 levels and allelic imbalance in 18q21 in colorectal cancer.
Watanabe T; Kanazawa T; Kazama Y; Tanaka J; Tanaka T; Ishihara S; Nagawa H
Clin Cancer Res; 2006 Mar; 12(5):1654; author reply 1654-5. PubMed ID: 16533795
[No Abstract] [Full Text] [Related]
[Next] [New Search]